Election 2014
SENSEX NIFTY

Sun Pharmaceutical

Apr 18, 2014 at 14:32 | Source: Reuters
Medicines produced in India, which supplies about 40 percent of generic and over-the-counter drugs sold in the United States, have come under increased scrutiny by the Food and Drug Administration over the past year.
Apr 15, 2014 at 14:16 | Source: Reuters
The Suprax recall is the second for India's fourth-largest drugmaker by sales, after pulling nearly 65,000 bottles from the US in January last year because of discoloration.
Apr 15, 2014 at 09:28 | Source: CNBC-TV18
Top 10 stocks to keep on your radar for April 15 are Tata Steel, Ambuja, Infosys, Rel Com, Mindtree, USL, MCX, CMC, Zee Ent, Sun Pharma.
Apr 15, 2014 at 09:06 | Source: Moneycontrol.com
Sun Pharmaceutical Industries makes an open offer to acquire up to 9,693,332 fully paid up equity shares of face value of Rs 10 each from the shareholders of Zenotech Laboratories.
Apr 15, 2014 at 08:11 | Source: CNBC-TV18
Infosys | DCB Bank | CMC | Gruh Finance | Tata Motors | Tata Power | AstraZeneca Pharma | United Spirits | Tata Steel | Coal India | Bharti Airtel | Ambuja Cements | SBI | NMDC | Zee Entertainment | Mindtree | Sun Pharma | Lupin | MCX and Zenotech Laboratories are stocks, which are in the news today.
Apr 12, 2014 at 13:21 | Source: CNBC-TV18
Tirthankar Patnaik, Director at Institutional Research, Religare Capital Markets recommends buying Infosys from the IT pack. He is overweight on IT and pharma.
Apr 12, 2014 at 11:56 | Source: CNBC-TV18
Tirthankar Patnaik bearish on financials and public sector lenders, but State Bank of India is the stock from the PSB pack which he likes.
Apr 11, 2014 at 22:29 | Source: PTI
Through the open offer, Sun Pharma plans to acquire more than 96 lakh shares of Zenotech, amounting to 28.1 percent. The price would be Rs 19 per share translating to an aggregate of Rs 18.42 crore, according to regulatory filing by Zenotech.
Apr 11, 2014 at 15:20 | Source: Moneycontrol.com
Brokerage house Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries and has recommended 'Accumulate' rating on the stock with a target price of Rs 646 in its research report dated April 09, 2014.
Apr 11, 2014 at 09:57 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, pharma stocks like Divis Labs, Sun Pharma,Ranbaxy, Strides Arcolab and Cipla will get astrological support.
Messages on Sun Pharmaceutical »

BSE/NSE Announcer

Platinum Member

2326 Followers

Sun Pharma  

With reference to earlier announcement dated April 15, 2014 regarding Shareholding Pattern For March 31, 2014, Sun Pharmaceutical Industries Ltd has now informed BSE that there was an inadvertent error in the total number of shares and Number of shares held in dematerialized form in Statement (I

12.50 PM Apr 17th

BSE/NSE Announcer

Platinum Member

2326 Followers

Sun Pharma  

Sun Pharmaceutical Industries Ltd has informed BSE about the Shareholding Pattern for the Quarter ended March 31, 2014.

11.04 AM Apr 15th

MMB Messenger

Platinum Member

213568 Followers

Pre markets  

Brokerage Recommendation: Sun Pharmaceutical Industries Company Report - Apr 11, 2014 : Prabhudas Lilladher

12.33 PM Apr 11th

Web Messenger

Platinum Member

208642 Followers

Sun Pharma  

Source:Business Today - (Picture for representation only) Photo: Reuters Sun Pharmaceutical Industries will fully acquire troubled Ranbaxy Laboratories, in an all-stock transaction with a total equity value of $3.2 billion.

3.50 PM Apr 10th

Web Messenger

Platinum Member

208642 Followers

Ranbaxy Labs  

Source:Business Today - The president of a brokerage association is planning to formally request that market regulator SEBI investigate trading in Ranbaxy Laboratories Ltd shares in the days leading up to its acquisition by Sun Pharmaceutical Industries. Ranbaxy shares surged 24 percent

3.50 PM Apr 10th

Web Messenger

Platinum Member

208642 Followers

Ranbaxy Labs  

Source:Economic Times - NEW DELHI: Market regulator Sebi has received multiple complaints about alleged irregularities in trading of Ranbaxy shares before the announcement of its multi-billion dollar merger deal with Sun Pharmaceutical. Securities and Exchange Board of India has started collating

3.40 PM Apr 10th

Web Messenger

Platinum Member

208642 Followers

Sun Pharma  

Source:Economic Times - HYDERABAD: Rating agency Crisil has reaffirmed its `A1 ` rating on bank facilities of Ranbaxy Laboratories post Sun Pharmaceutical Industries`s announcement to acquire 100 per cent stake in it. The deal is valued at an enterprise value of US $ 4 billion on an all

3.40 PM Apr 10th

Web Messenger

Platinum Member

208642 Followers

Sun Pharma  

Source:Economic Times - MUMBAI: Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States after completing a $3.2 billion takeover of its loss-making rival, sources with direct knowledge of the matter said

7.35 PM Apr 9th

niftynewbie

Platinum Member

68 Followers

Ranbaxy Labs  

http://t.in.com/0Fi3 At a time when many are closely watching the Ranbaxy Laboratories scrip, Silverstreet Developers, a limited liability partnership firm with Sun Pharmaceuticals’ Sudhir V Valia as one of the partners, has picked up a 1.41 per cent

7.08 PM Apr 9th

MMB Messenger

Platinum Member

213568 Followers

Market Analysis - Fundamental View  

Brokerage Recommendation: Sun Pharmaceutical Event Update - Apr 09, 2014 : Systematix Shares

6.31 PM Apr 9th

News across the web »
Apr 18, 2014 at 14:36 | Source: Business Today
Apr 17, 2014 at 12:37 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.